<unk>  growth factor (NGF)<unk> s are a class of compounds that inhibit the action of the neurotrophin<unk>  growth factor by targeting NGF molecules or NGF receptors. NGF<unk> s have demonstrated therapeutic potential in treatment of certain chronic pain disorders, including osteoarthritis, and chronic lower back pain. Two NGF<unk> s (tanezumab, and fasinumab) are undergoing clinical trials as potential treatments for pain disorders.
Nerve growth factor inhibitor
Growth factor receptor inhibitor
Orexin antagonist
Endopeptidase inhibitor
Neurosteroidogenesis inhibitor
Reuptake inhibitor
Serotonin releasing agent
Dopamine antagonist